Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Hope Dairy is a leading Chinese dairy enterprise that has evolved into a technology-driven company focusing on functional nutrition and biotechnology. Operating under its signature Fresh Strategy, the company integrates regional dairy brands and emphasizes high-end liquid milk products with short shelf lives. The company maintains a robust R&D infrastructure, including the New Hope Dairy Research Institute, which focuses on the isolation and characterization of proprietary probiotic strains for gut health and immunity. Their commercial portfolio features functional products enriched with specific strains like Bifidobacterium lactis TY-S01 and Lactobacillus rhamnosus GRX10. By combining advanced fermentation technologies with a sophisticated cold-chain logistics network, New Hope Dairy addresses the increasing consumer demand for health-enhancing dairy products. The company is publicly listed on the Shenzhen Stock Exchange and collaborates extensively with academic institutions to advance nutritional science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Hope Dairy.